563 related articles for article (PubMed ID: 16529163)
1. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
Machoy M
Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
Sieradzki J; Soszyński P
Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
[TBL] [Abstract][Full Text] [Related]
3. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
[TBL] [Abstract][Full Text] [Related]
4. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
Johnson JL; Wolf SL; Kabadi UM
Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes in primary care in belgium: need for structured shared care.
Goderis G; Borgermans L; Heyrman J; Broeke CV; Grol R; Boland B; Mathieu C
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):367-72. PubMed ID: 19358093
[TBL] [Abstract][Full Text] [Related]
8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
9. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
10. [Differences between diabetes mellitus type 2 patients switched and not switched over to insulin treatment after specialist consultation].
Goddijn PP; Meyboom-de Jong B; Feskens EJ; van Ballegooie E; Bilo HJ
Ned Tijdschr Geneeskd; 1998 May; 142(18):1023-6. PubMed ID: 9623204
[TBL] [Abstract][Full Text] [Related]
11. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
[TBL] [Abstract][Full Text] [Related]
12. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
[TBL] [Abstract][Full Text] [Related]
13. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy].
Dakhli S; Lamine S; Lamine F; Trabelsi N; Aouididi F; Zouaoui C; Mami FB; Achour A
Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with switching from oral hypoglycaemic agents to insulin therapy.
Spoelstra JA; Stol RP; de Bruyne MC; Erkens JA; Herings RM; Leufkens HG; Grobbee DE
Neth J Med; 2002 Jul; 60(6):243-8. PubMed ID: 12365467
[TBL] [Abstract][Full Text] [Related]
15. The combination of insulin and oral hypoglycaemic drugs: a continuous challenge.
Quatraro A; Giugliano D
Diabete Metab; 1993; 19(2):219-24. PubMed ID: 8339852
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of "complex" patients with type 2 diabetes mellitus according to their primary care physicians.
Grant RW; Wexler DJ; Ashburner JM; Hong CS; Atlas SJ
Arch Intern Med; 2012 May; 172(10):821-3. PubMed ID: 22636827
[No Abstract] [Full Text] [Related]
17. Hypertension and related risk factors in type 2 diabetes mellitus.
Lunetta M; Barbagallo A; Crimi S; Di Mauro M; Sangiorgio L; Mughini L
Minerva Endocrinol; 1999 Jun; 24(2):45-50. PubMed ID: 10941422
[TBL] [Abstract][Full Text] [Related]
18. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
Gulliford MC; Charlton J; Latinovic R
J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
[TBL] [Abstract][Full Text] [Related]
19. Combination-therapy with bedtime nph insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes.
Olsson PO; Lindström T
Diabetes Metab; 2002 Sep; 28(4 Pt 1):272-7. PubMed ID: 12442064
[TBL] [Abstract][Full Text] [Related]
20. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
